APA Citatie

Roux, P., Sullivan, M. A., Cohen, J., Fugon, L., Jones, J. D., Vosburg, S. K., . . . Comer, S. D. (2013). Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: Reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Chicago Style citaat

Roux, Perrine, et al. Buprenorphine/naloxone As a Promising Therapeutic Option for Opioid Abusing Patients With Chronic Pain: Reduction of Pain, Opioid Withdrawal Symptoms, and Abuse Liability of Oral Oxycodone. 2013.

MLA citatie

Roux, Perrine, et al. Buprenorphine/naloxone As a Promising Therapeutic Option for Opioid Abusing Patients With Chronic Pain: Reduction of Pain, Opioid Withdrawal Symptoms, and Abuse Liability of Oral Oxycodone. 2013.

Let op: Deze citaties zijn niet altijd 100% accuraat.